|
The approved abbreviated new drug application (ANDA) is a generic version of Effient (Prasugrel) tablets of Cosette Pharmaceuticals, Inc.
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events (including stent thrombosis) in patients with acute coronary syndrome.
The drug will be commercialized from Unichem's Goa plant.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
The company reported a consolidated net loss of Rs 44.27 crore in Q4 FY23 as against net profit of Rs 71.47 crore in Q4 FY22. Net sales rose 8.78% YoY to Rs 402.10 crore in the quarter ended 31 March 2023.
Shares of Unichem Laboratories were up 0.17% to Rs 417.80 on the BSE.
|